Natixis Syneos Health, Inc. Transaction History

Natixis

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$34.5 - $42.19 $526,470 - $643,819	-15,260 Reduced 14.82%	87,740 $3.7 Million
Q1 2023 May 12, 2023	BUY	$33.32 - $40.98 $3.43 Million - $4.22 Million	103,000 New	103,000 $3.67 Million
Q4 2021 Feb 14, 2022	SELL	$86.01 - $102.89 $1.73 Million - $2.07 Million	-20,100 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$84.7 - $96.31 $1.7 Million - $1.94 Million	20,100 New	20,100 $1.76 Million
Q1 2021 May 14, 2021	SELL	$67.36 - $80.76 $2.95 Million - $3.54 Million	-43,800 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$53.08 - $69.86 $2.32 Million - $3.06 Million	43,800 New	43,800 $2.98 Million
Q3 2018 Nov 14, 2018	SELL	$46.5 - $53.55 $3.46 Million - $3.99 Million	-74,484 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$35.0 - $48.9 $2.61 Million - $3.64 Million	74,484 New	74,484 $3.49 Million

731K

Ticker SYNH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,653,000
Description
Syneos Health, Inc. provides biopharmaceutical outsourcing solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, de...

Get notified when there are updates to the investment portfolio of Natixis, based on Form 13F filings with the SEC.

Stay updated on Natixis with notifications on news.